Febs Tablet contains Febuxostat 40mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat works by selectively inhibiting xanthine oxidase, an enzyme responsible for converting purines into uric acid, thereby reducing serum uric acid levels. This reduction helps prevent gout attacks, which are caused by the accumulation of uric acid crystals in joints, leading to inflammation and pain. Febs Tablet is typically prescribed for patients who have not responded well to other urate-lowering therapies or who are intolerant to allopurinol. It is important to take this medication exactly as directed by a healthcare professional, usually once daily, with or without food. Patients should inform their doctor about any history of liver or kidney disease, cardiovascular conditions, or allergies before starting treatment. Common side effects may include nausea, joint pain, rash, or liver enzyme abnormalities, and any unusual symptoms should be reported promptly. Regular monitoring of uric acid levels and liver function tests is recommended during therapy to ensure safety and efficacy. Febs Tablet is not intended for use in acute gout attacks but rather for long-term management to prevent flare-ups and improve quality of life.